Emine Meltem

ORCID: 0000-0003-3927-321X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Artificial Intelligence in Healthcare and Education
  • Radiomics and Machine Learning in Medical Imaging
  • Hearing Loss and Rehabilitation
  • Palliative Care and End-of-Life Issues
  • Hearing, Cochlea, Tinnitus, Genetics
  • Cancer survivorship and care
  • MRI in cancer diagnosis
  • AI in cancer detection
  • Advanced X-ray and CT Imaging
  • Ultrasound Imaging and Elastography
  • Ear Surgery and Otitis Media
  • Dialysis and Renal Disease Management
  • Breast Cancer Treatment Studies
  • Radiology practices and education
  • Vascular Procedures and Complications
  • Patient-Provider Communication in Healthcare
  • Advanced Breast Cancer Therapies
  • Breast Lesions and Carcinomas
  • Cancer Treatment and Pharmacology
  • Central Venous Catheters and Hemodialysis

Sağlık Bilimleri Üniversitesi
2023-2025

University of Health Sciences Antigua
2023-2024

Eastern Mediterranean University
2020

Marmara University
2007

Abstract Objectives To develop an efficient deep learning (DL) model for breast cancer detection in mammograms, utilizing both weak (image-level) and strong (bounding boxes) annotations providing explainable artificial intelligence (XAI) with gradient-weighted class activation mapping (Grad-CAM), assessed by the ground truth overlap ratio. Methods Three radiologists annotated a balanced dataset of 1976 mammograms (cancer-positive -negative) from three centers. We developed patch-based DL...

10.1186/s13244-025-01922-w article EN cc-by Insights into Imaging 2025-03-19

Abstract Background A valid measure to describe the most important needs and concerns of people with life-threatening illnesses is missing in Cyprus. Our aim was adapt test cross-cultural validity responsiveness Integrated Palliative care Outcome Scale (IPOS) a cohort Turkish speaking cancer patients. Methods The IPOS (English) patient-reported translated into following published guidelines including, 2 independent forward, blind backward translations, expert panel review by 7 members field...

10.1186/s12955-020-01535-5 article EN cc-by Health and Quality of Life Outcomes 2020-09-22

Abstract Aim This study aimed to assess the predictive role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte lymphocyte-to-monocyte and mean platelet volume, on catheter survival in chronic hemodialysis patients, analyzing both infectious non-infectious complications. Methods A retrospective analysis encompassed 1279 tunneled insertion procedures involving 902 patients between March 2014 October 2018. Patients were categorized into two main groups: (i) initial placement (ii)...

10.1007/s40620-023-01880-w article EN cc-by Journal of Nephrology 2024-03-21

Preoperative assessment of the cochlear duct length (CDL) and dimensions allows selection optimized implants. We aimed to evaluate CDL measurements in incomplete partition (IP) defect patients create a reference literature.Forty-one with IP (13 I, 23 II, 5 III) 30 controls were included study. The standardized image showing basal turn most expansive plane was reconstructed from temporal high-resolution computed tomography images. Cochlear measured manually (CDL-M) by points placed...

10.1097/rct.0000000000001488 article EN Journal of Computer Assisted Tomography 2023-05-26

Objectives:The purpose of the study was to evaluate cochlea dimensions by multiplanar reconstruction high-resolution computed tomography that could be useful in diagnosing incomplete partition (IP) malformations.Methods: This included 32 patients with 64 side cochleae diagnosed IP defect and 38 as control without any defect.Basal turn length (BL), cochlear height (CH), Mid-apical (MAL), height, Cochlear (A), width (B) were measured on reformat images.Results: Twenty these have been type I,...

10.14744/semb.2023.65725 article EN SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital 2023-01-01

11102 Background: Breast cancer patients (pts) with NN disease have diverse clinical outcomes. An optimal treatment decision- making tool has not been defined for this heterogeneous group. Methods: We identified pts who treated between 1998–2006 in our department. recorded the clinical/pathological, characteristics and analyzed their survival outcome. High risk (HR) was as having at least one of following features: age<35 yr-old, grade 3 tumors (tms), ER PR negative tms, tm size >2 cm....

10.1200/jco.2007.25.18_suppl.11102 article EN Journal of Clinical Oncology 2007-06-20
Coming Soon ...